196 related articles for article (PubMed ID: 27517156)
1. Suppression of breast cancer metastasis through the inactivation of ADP-ribosylation factor 1.
Xie X; Tang SC; Cai Y; Pi W; Deng L; Wu G; Chavanieu A; Teng Y
Oncotarget; 2016 Sep; 7(36):58111-58120. PubMed ID: 27517156
[TBL] [Abstract][Full Text] [Related]
2. Structure-based discovery of an inhibitor of Arf activation by Sec7 domains through targeting of protein-protein complexes.
Viaud J; Zeghouf M; Barelli H; Zeeh JC; Padilla A; Guibert B; Chardin P; Royer CA; Cherfils J; Chavanieu A
Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10370-5. PubMed ID: 17563369
[TBL] [Abstract][Full Text] [Related]
3. ARF1 regulates adhesion of MDA-MB-231 invasive breast cancer cells through formation of focal adhesions.
Schlienger S; Ramirez RA; Claing A
Cell Signal; 2015 Mar; 27(3):403-15. PubMed ID: 25530216
[TBL] [Abstract][Full Text] [Related]
4. ARF1 controls Rac1 signaling to regulate migration of MDA-MB-231 invasive breast cancer cells.
Lewis-Saravalli S; Campbell S; Claing A
Cell Signal; 2013 Sep; 25(9):1813-9. PubMed ID: 23707487
[TBL] [Abstract][Full Text] [Related]
5. Recruitment of Arf1-GDP to Golgi by Glo3p-type ArfGAPs is crucial for golgi maintenance and plant growth.
Min MK; Jang M; Lee M; Lee J; Song K; Lee Y; Choi KY; Robinson DG; Hwang I
Plant Physiol; 2013 Feb; 161(2):676-91. PubMed ID: 23266962
[TBL] [Abstract][Full Text] [Related]
6. ADP-ribosylation factor 1 expression regulates epithelial-mesenchymal transition and predicts poor clinical outcome in triple-negative breast cancer.
Schlienger S; Campbell S; Pasquin S; Gaboury L; Claing A
Oncotarget; 2016 Mar; 7(13):15811-27. PubMed ID: 26908458
[TBL] [Abstract][Full Text] [Related]
7. Podosome assembly is controlled by the GTPase ARF1 and its nucleotide exchange factor ARNO.
Rafiq NB; Lieu ZZ; Jiang T; Yu CH; Matsudaira P; Jones GE; Bershadsky AD
J Cell Biol; 2017 Jan; 216(1):181-197. PubMed ID: 28007915
[TBL] [Abstract][Full Text] [Related]
8. ADP-ribosylation factor 1 controls the activation of the phosphatidylinositol 3-kinase pathway to regulate epidermal growth factor-dependent growth and migration of breast cancer cells.
Boulay PL; Cotton M; Melançon P; Claing A
J Biol Chem; 2008 Dec; 283(52):36425-34. PubMed ID: 18990689
[TBL] [Abstract][Full Text] [Related]
9. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models.
Li Y; Drabsch Y; Pujuguet P; Ren J; van Laar T; Zhang L; van Dam H; Clément-Lacroix P; Ten Dijke P
Breast Cancer Res; 2015 Feb; 17(1):28. PubMed ID: 25849225
[TBL] [Abstract][Full Text] [Related]
10. Combined targeting of Arf1 and Ras potentiates anticancer activity for prostate cancer therapeutics.
Lang L; Shay C; Zhao X; Teng Y
J Exp Clin Cancer Res; 2017 Aug; 36(1):112. PubMed ID: 28830537
[TBL] [Abstract][Full Text] [Related]
11. Functional disruption of the Golgi apparatus protein ARF1 sensitizes MDA-MB-231 breast cancer cells to the antitumor drugs Actinomycin D and Vinblastine through ERK and AKT signaling.
Luchsinger C; Aguilar M; Burgos PV; Ehrenfeld P; Mardones GA
PLoS One; 2018; 13(4):e0195401. PubMed ID: 29614107
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of the Arf1*GTP/Arf GAP interface reveals an Arf1 mutant that selectively affects the Arf GAP ASAP1.
Luo R; Jacques K; Ahvazi B; Stauffer S; Premont RT; Randazzo PA
Curr Biol; 2005 Dec; 15(23):2164-9. PubMed ID: 16332543
[TBL] [Abstract][Full Text] [Related]
13. IGF-1 drives chromogranin A secretion via activation of Arf1 in human neuroendocrine tumour cells.
Münzberg C; Höhn K; Krndija D; Maaß U; Bartsch DK; Slater EP; Oswald F; Walther P; Seufferlein T; von Wichert G
J Cell Mol Med; 2015 May; 19(5):948-59. PubMed ID: 25754106
[TBL] [Abstract][Full Text] [Related]
14. The adaptor proteins p66Shc and Grb2 regulate the activation of the GTPases ARF1 and ARF6 in invasive breast cancer cells.
Haines E; Saucier C; Claing A
J Biol Chem; 2014 Feb; 289(9):5687-703. PubMed ID: 24407288
[TBL] [Abstract][Full Text] [Related]
15. Class I Arfs (Arf1 and Arf3) and Arf6 are localized to the Flemming body and play important roles in cytokinesis.
Hanai A; Ohgi M; Yagi C; Ueda T; Shin HW; Nakayama K
J Biochem; 2016 Feb; 159(2):201-8. PubMed ID: 26330566
[TBL] [Abstract][Full Text] [Related]
16. An Arf1 GTPase mutant with different responses to GEF inhibitors.
Flisiak S; Zeeh JC; Guibert B; Cherfils J; Zeghouf M
Biochem Biophys Res Commun; 2008 Dec; 377(1):156-60. PubMed ID: 18834864
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of ADP-ribosylation factor 1 in human gastric carcinoma and its clinicopathological significance.
Tsai MM; Lin PY; Cheng WL; Tsai CY; Chi HC; Chen CY; Tseng YH; Cheng YF; Chen CD; Liang Y; Liao CJ; Wu SM; Lin YH; Chung IH; Wang CS; Lin KH
Cancer Sci; 2012 Jun; 103(6):1136-44. PubMed ID: 22348287
[TBL] [Abstract][Full Text] [Related]
18. Recruitment to Golgi membranes of ADP-ribosylation factor 1 is mediated by the cytoplasmic domain of p23.
Gommel DU; Memon AR; Heiss A; Lottspeich F; Pfannstiel J; Lechner J; Reinhard C; Helms JB; Nickel W; Wieland FT
EMBO J; 2001 Dec; 20(23):6751-60. PubMed ID: 11726511
[TBL] [Abstract][Full Text] [Related]
19. AMF-26, a novel inhibitor of the Golgi system, targeting ADP-ribosylation factor 1 (Arf1) with potential for cancer therapy.
Ohashi Y; Iijima H; Yamaotsu N; Yamazaki K; Sato S; Okamura M; Sugimoto K; Dan S; Hirono S; Yamori T
J Biol Chem; 2012 Feb; 287(6):3885-97. PubMed ID: 22158626
[TBL] [Abstract][Full Text] [Related]
20. Correct targeting of plant ARF GTPases relies on distinct protein domains.
Matheson LA; Suri SS; Hanton SL; Chatre L; Brandizzi F
Traffic; 2008 Jan; 9(1):103-20. PubMed ID: 17988226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
